-
1 month ago | 
neurologylive.com | Bruce F Bebo |Isabella Ciccone
WATCH TIME: 2 minutes"What often sets some of the prize winners apart is that these discoveries have led to something translational, something that has ultimately resulted in the development of disease-modifying or other therapies that benefit people living with MS.”Recognition of research in multiple sclerosis (MS) provides an opportunity to highlight the efforts of investigators who contribute to advancing clinicians’ understanding of the disease.
-
2 months ago | 
neurologylive.com | Isabella Ciccone |Bruce F Bebo |Amit Bar-Or
Recent advancements in multiple sclerosis (MS) research have significantly enhanced clinicians’ understanding of the disease's pathogenesis and treatment.
-
2 months ago | 
neurologylive.com | Bruce F Bebo |Isabella Ciccone
WATCH TIME: 5 minutes “I think we’ll look back—when the cures are found for MS—and we’ll see these lectures at the Academy meeting as milestones and significant jumps in our understanding of MS that led to those cures.” The John Dystel Prize for Multiple Sclerosis Research, presented by the National Multiple Sclerosis Society (the Society) in partnership with the American Academy of Neurology (AAN), honors exceptional research that has significantly advanced the understanding, prevention,...
-
Feb 27, 2025 | 
neurologylive.com | Bruce F Bebo |Isabella Ciccone
WATCH TIME: 5 minutes"Studies published just a year or so ago queried electronic medical records using AI algorithms to look for patterns in healthcare utilization and groups of people who went on to develop MS compared [with] those who did not.
-
Feb 27, 2025 | 
neurologylive.com | Bruce F Bebo |Isabella Ciccone
WATCH TIME: 4 minutes "Even when you have [patients] on these high-efficacy therapies and almost completely suppressing relapses, you still notice this slow progression." The 2025 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum, held February 27 to March 1, in West Palm Beach, Florida, spotlights the latest breakthroughs in MS research, with a strong focus on smoldering neuroinflammation, progression independent of relapse activity (PIRA), and innovative...
-
Apr 15, 2024 | 
neurologylive.com | Bruce F Bebo
WATCH TIME: 3 minutes"Prizes like the Dystel Prize help elevate and recognize excellence in MS research and create excitement and interest, promoting MS as a specialty that deserves to be studied and investigated."Rhonda Voskuhl, MD, director of the Multiple Sclerosis Program at University of California, Los Angeles (UCLA), received the 2024 John Dystel Prize for Multiple Sclerosis Research.
-
Oct 27, 2023 | 
todayschronic.com | Bruce F Bebo |Margaret Jenner
By Bruce Bebo, PhD, as told to Hallie LevineI've been part of the leadership team for the National Multiple Sclerosis Society for a decade. I was inspired to pursue this advocacy work because my mother was diagnosed with the disease when I was a child. Back then, there were virtually no treatments for her, and she suffered unnecessarily. As a kid, I vowed I'd do everything in my power to change that. Today, the outlook for people diagnosed with MS is much different.
-
Aug 23, 2023 | 
neurologylive.com | Bruce F Bebo
WATCH TIME: 4 minutes"Early trials of promyelinating agents have shown that remyelination in humans is possible, I think the roadblock is demonstrating the clinical benefit of those approaches.
-
Aug 17, 2023 | 
neurologylive.com | Bruce F Bebo
WATCH TIME: 4 minutes"There are emerging biomarkers like neurofilament light chain or glial fibrillary acidic protein that might help accelerate the development of therapies for that neurodegenerative phase in progressive forms of MS."Patients with progressive-relapsing phenotypes of multiple sclerosis (MS) can be grouped in 4 subgroups: active with progression, active but without progression, inactive with progression, and stable without disease activity and progression.
-
Aug 9, 2023 | 
notiulti.com | Bruce F Bebo
Recientemente, el Sociedad Nacional de EM anunció un compromiso de $19,4 millones para la hoja de ruta de investigación Pathways to Cures de la sociedad, una iniciativa a gran escala con la esperanza de acelerar los avances científicos para curar la esclerosis múltiple (EM).
